Later this year, likely in November, Johnson and Johnson will be spinning off its consumer products unit. Brands like Tylenol, Listerine, Band-Aid and Neutrogena will go under a new business ...

Wells Fargo analyst Larry Biegelsen maintained a Hold rating on Johnson & Johnson (JNJ – Research Report) yesterday and set a price target ...

Johnson & Johnson “should have known that the J&J Products contained harmful, deleterious, carcinogenic and inherently dangerous asbestos dust and fibers” and the products reportedly did not ...

In the United States, Johnson’s, part of the Johnson & Johnson Family of Consumer Companies, invested time and talent in Save the Children’s community and home visitation early childhood development ...

Johnson & Johnson denies asbestos was in its products. CBS News reported that ... It also split off the consumer-health portion of the company into a new one called Kenvue, which sells the ...

Analyst Terence Flynn from Morgan Stanley maintained a Hold rating on Johnson & Johnson (JNJ – Research Report) and keeping the price ...

In 2021, Johnson & Johnson unveiled a plan to spin off its consumer products division to focus on pharmaceuticals and medical technology. The company completed the Kenvue spinoff to shareholders ...

Both these factors can be tied in part to J&J’s strong presence in the consumer ... products is a strong pharmaceutical backbone that has emerged over the company’s long and varied history ...